Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylphenidate sensitization is modulated by valproate.

K Eckermann1, A Beasley, P Yang

  • 1Department of Neurobiology and Anatomy, The University of Texas Medical School at Houston, 77225, USA.

Life Sciences
|June 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Australian guidelines for equine internal parasite management.

Australian veterinary journal·2025
Same author

Age differences to methylphenidate-NAc neuronal and behavioral recordings from freely behaving animals.

Journal of neural transmission (Vienna, Austria : 1996)·2022
Same author

Adolescent rats respond differently to methylphenidate as compared to adult rats- concomitant VTA neuronal and behavioral Recordings.

Brain research bulletin·2022
Same author

Comparisons of PNEC derivation logic flows under example regulatory schemes and implications for ecoTTC.

Regulatory toxicology and pharmacology : RTP·2021
Same author

Response to "Comment on 'Mode of Action (MOA) Assignment Classifications for Ecotoxicology: An Evaluation of Approaches'".

Environmental science & technology·2017
Same author

Mode of Action (MOA) Assignment Classifications for Ecotoxicology: An Evaluation of Approaches.

Environmental science & technology·2017
Same journal

Corrigendum to "Adipose stem cells-derived microvesicles and chicken egg-derived exosomes attenuate cardiac ischemia/reperfusion injury through AKT/ERK/Nrf2/HO-1 axis to inhibit apoptosis and inflammation and restore autophagy" [Life Sci. 395 (2026) 124364].

Life sciences·2026
Same journal

MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

Life sciences·2026
Same journal

TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

Life sciences·2026
Same journal

Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

Life sciences·2026
Same journal

Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

Life sciences·2026
Same journal

METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

Life sciences·2026
See all related articles

Sodium valproate (VAL) affects methylphenidate (MPD) responses in rats. Low-dose VAL blocked MPD sensitization, suggesting a role for GABAergic agents in stimulant-induced behavioral changes.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Repeated stimulant administration, like methylphenidate (MPD), can lead to behavioral sensitization.
  • Glutamate, dopamine, and GABA neurotransmitter systems are implicated in stimulant sensitization mechanisms.
  • The role of GABAergic agents in modulating MPD-induced sensitization requires further investigation.

Purpose of the Study:

  • To investigate the effects of the GABAergic agent sodium valproate (VAL) on the locomotor response to MPD.
  • To determine if VAL can alter acute MPD effects and block the development of behavioral sensitization.

Main Methods:

  • Male Sprague-Dawley rats' locomotor activity was monitored continuously for 15 days using a computerized system.
  • Rats received varying doses of VAL (50, 100, 200 mg/kg) alone, with acute MPD (2.5 mg/kg), or during repeated MPD administration.

Related Experiment Videos

  • Effects on motor activity and the development of behavioral sensitization to MPD were assessed.

    • Main Results:

    • Sodium valproate administration alone did not significantly alter baseline motor activity.
    • All tested doses of VAL attenuated the acute locomotor effects induced by MPD.
    • Only the 50 mg/kg dose of VAL effectively blocked the development of behavioral sensitization to repeated MPD administration.

    Conclusions:

    • GABAergic modulation via sodium valproate can significantly impact the acute locomotor effects of methylphenidate.
    • Low-dose sodium valproate demonstrates potential in blocking the development of behavioral sensitization to methylphenidate.
    • These findings suggest specific GABAergic mechanisms may underlie stimulant-induced sensitization.